Crossmark

Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer

Crossref DOI link: https://doi.org/10.1007/s12032-017-1029-8

Published Online: 2017-09-01

Published Print: 2017-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Katz, Heather

Wassie, Emnet

Alsharedi, Mohamed https://orcid.org/0000-0002-6636-382X
License Information

Text and Data Mining valid from 2017-09-01
More Information

Article History

Received: 31 July 2017

Accepted: 22 August 2017

First Online: 1 September 2017

Compliance with ethical standards

:

: All authors declare that they have no conflict of interest.

: No animal or human were involved in this study.